Equity research that gets to the core of data
Discovery starts with looking where others haven’t. Our technology-driven approach allows us to efficiently mine large amounts of data using reliable resources, including Bloomberg, FactSet, and our strategic partnerships with best-in-class providers.
Once we’ve analyzed data to derive quality from quantity, we deliver a compact investment thesis that highlights your small-cap company’s core financial story. A fair valuation attracts meaningful interest to impact liquidity and access to capital.
Fact-based investment analysis, not recommendations, lets your story speak for itself.
This page is dedicated to the press announcement for JGR Capital’s KaloBios Pharmaceuticals Initial Coverage Report (KBIO).
JGR Capital’s full KaloBios Pharmaceuticals Initial Coverage Report can be found here:
This page is dedicated to the press announcement of JGR Capital’s Zivo Bioscience Initial Coverage (ZIVO).
The full report is available at this PDF link:
New York, NY, February 13, 2017 –(PR.com)– JGR Capital, a leading equity research and digital investor relations firm, has announced it has released an update on BioCorRx (OTC PINK: BICX).
The full report can be found at www.jgrcap.com
BioCorRx working with Innovative Science Solutions for regulatory matters
BioCorRx Inc. announced on […]
NEW YORK, NY / ACCESSWIRE / January 19, 2017 / JGR Capital, a leading equity research and digital investor relations firm, has announced it has initiated coverage on BioCorRx (OTC PINK: BICX) with a price target of $0.09.
The full report can be found here: BICX Initiation
BioCorRx operates in the […]